Posts published by our team from April 7th to April 12th:
April 6th: 阴谋论可以休矣！全球顶尖科学家最新研究成果：新冠病毒不可能由人类合成
This is our first translation and was written by William Ding. This article was translated into Simplified Chinese.
Researchers at the National University of Singapore looked at inflammatory changes in the early stages of nCoV-19 infection to get a better understanding of how COVID-19 shapes immune responses. They found that in addition to increasing levels of inflammatory cytokines, nCoV-19 may also suppress the inflammatory immune response.
An international team lead by researchers at the University of British Columbia have found that hrsACE2, a drug already tested in phase I and II clinical trials, can significantly reduce nCoV-19 infection rates in cells and engineered human tissues. The researchers also showed the nCoV-19 can infect engineered human blood vessels and engineered human kidneys, and that hrsACE2 significantly reduces the infection of these tissues as well.